These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31435916)

  • 41. [Importance of intrathecal pain therapy].
    Likar R; Ilias W; Kloimstein H; Kofler A; Kress HG; Neuhold J; Pinter MM; Spendel MC
    Schmerz; 2007 Feb; 21(1):15-8, 20-4, 26-7. PubMed ID: 17109113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient management of cerebral origin spasticity with intrathecal baclofen.
    Rawlins P
    J Neurosci Nurs; 1998 Feb; 30(1):32-5, 40-6. PubMed ID: 9604821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
    Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
    J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks.
    Deer TR; Pope JE; Hayek SM; Lamer TJ; Veizi IE; Erdek M; Wallace MS; Grider JS; Levy RM; Prager J; Rosen SM; Saulino M; Yaksh TL; De Andrés JA; Abejon Gonzalez D; Vesper J; Schu S; Simpson B; Mekhail N
    Neuromodulation; 2017 Feb; 20(2):155-176. PubMed ID: 28042914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Motor function improvement following intrathecal baclofen pump placement in a patient with locked-in syndrome.
    Cairns K; Stein J
    Am J Phys Med Rehabil; 2002 Apr; 81(4):307-9. PubMed ID: 11953549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subfascial implantation of intrathecal baclofen pumps in children: technical note.
    Kopell BH; Sala D; Doyle WK; Feldman DS; Wisoff JH; Weiner HL
    Neurosurgery; 2001 Sep; 49(3):753-6; discussion 756-7. PubMed ID: 11523691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrathecal Pumps.
    Ericson T; Singla P; Kohan L
    Phys Med Rehabil Clin N Am; 2022 May; 33(2):409-424. PubMed ID: 35526977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrathecal antispastic drug application with implantable pumps: results of a 10 year follow-up study.
    Koulousakis A; Kuchta J
    Acta Neurochir Suppl; 2007; 97(Pt 1):181-4. PubMed ID: 17691374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrathecal baclofen in cerebral palsy movement disorders.
    Albright AL
    J Child Neurol; 1996 Nov; 11 Suppl 1():S29-35. PubMed ID: 8959459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrathecal baclofen use in the management of tetanus related spasm: A case report.
    Şık G; Aydoseli A; Çıtak A
    Turk J Pediatr; 2019; 61(1):126-129. PubMed ID: 31559734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managing spasticity in spinal cord injury: safe administration of bridge boluses during intrathecal baclofen pump refills.
    Elovic E; Kirshblum SC
    J Spinal Cord Med; 2003; 26(1):2-4. PubMed ID: 12830961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.
    Postma TJ; Oenema D; Terpstra S; Bouma J; Kuipers-Upmeijer H; Staal MJ; Middel BJ
    Pharmacoeconomics; 1999 Apr; 15(4):395-404. PubMed ID: 10537958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrathecal baclofen therapy and the child with cerebral palsy.
    Vitztum C; Olney B
    Orthop Nurs; 2000; 19(1):43-8. PubMed ID: 11062623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of intrathecal baclofen delivery in the management of severe spasticity in upper motor neuron syndrome.
    Rietman JS; Geertzen JH
    Acta Neurochir Suppl; 2007; 97(Pt 1):205-11. PubMed ID: 17691378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrathecal Drug Delivery for Chronic Pain Syndromes: A Review of Considerations in Practice Management.
    Abd-Elsayed A; Karri J; Michael A; Bryce D; Sun J; Lee M; Orhurhu V; Deer T
    Pain Physician; 2020 Nov; 23(6):E591-E617. PubMed ID: 33185379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrathecal Baclofen Infusion Pumps in the Treatment of Spasticity: A Retrospective Cohort Study in a Portuguese Centre.
    Reis PV; Vieira CR; Midões AC; Rebelo V; Barbosa P; Gomes A
    Acta Med Port; 2019 Dec; 32(12):754-759. PubMed ID: 31851884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ziconotide: a clinical update and pharmacologic review.
    Pope JE; Deer TR
    Expert Opin Pharmacother; 2013 May; 14(7):957-66. PubMed ID: 23537340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients.
    Plassat R; Perrouin Verbe B; Menei P; Menegalli D; Mathé JF; Richard I
    Spinal Cord; 2004 Dec; 42(12):686-93. PubMed ID: 15303111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy of intrathecal baclofen in the treatment of spasticity in stroke].
    Lamotte D; Cantalloube S
    Ann Readapt Med Phys; 2007 Apr; 50(3):165-9. PubMed ID: 17145092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.